ANNUAL REPORT

Company

Sonoma Pharmaceuticals, Inc.

Filed

June 16, 2015

Period of Report

March 31, 2015

Accession Number

0001019687-15-002432

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →